A key reason positions haven't been filled is that they require travel that ranges from 25% to 75% of the time.
The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...
Dallas Morning News on MSN6d
FDA adds new warning to weight loss drugs including WegovyThe FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...
Cryptopolitan on MSN11d
FDA’s new device chief faces growing pressure as AI and tech transform healthcareDr. Michelle Tarver, a veteran of the Food and Drug Administration (FDA), has taken charge of the FDA’s device division at a ...
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
The environmental lawyer’s many controversial statements are rallying state lawmakers to pay close attention to Connecticut’s ...
Aucatzyl is the first CAR-T cell therapy approved by the FDA with no requirement for a risk evaluation mitigation strategy ...
Johnson & Johnson MedTech announced today that the FDA granted its Ottava surgical robot investigational device exemption ...
Almost every food brand has been affected by product recalls at some point, and Hostess is no different. These are some of ...
Less than a month after the FDA removed Eli Lilly’s tirzepatide from its shortage list, the agency has done the same for Novo Nordisk’s rival GLP-1 semaglutide, potentially signaling the end of a d | ...
CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from the FDA ...
The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback